Tuesday, April 30, 2019

Integrin a10 - a new target for glioblastomas



As we have discussed before,

https://adcdaily.blogspot.com/2019/04/adcs-for-glioblastoma.html

getting after glioblastoma is hard.  Here a group from Lund Sweden has identified a new potential target for ADC therapeutics.

https://www.mdpi.com/2072-6694/11/4/587/htm

The preliminary results look very encouraging, however the fact remains, that if curing cancer in humans was as easy as curing cancer in mice, cancer would have been eliminated a long time ago.

What do you think?  Are these types of discoveries things to get excited about? Seeds for a new biotech company?  Or just another academic discovery with no application in the real world?



No comments:

Post a Comment